Metropolitan Life Insurance Co NY Sells 14,928 Shares of Medidata Solutions Inc (NASDAQ:MDSO)

Metropolitan Life Insurance Co NY cut its position in shares of Medidata Solutions Inc (NASDAQ:MDSO) by 42.4% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 20,306 shares of the company’s stock after selling 14,928 shares during the quarter. Metropolitan Life Insurance Co NY’s holdings in Medidata Solutions were worth $1,858,000 as of its most recent SEC filing.

Several other institutional investors have also recently made changes to their positions in MDSO. First Trust Advisors LP increased its position in shares of Medidata Solutions by 347.4% during the 1st quarter. First Trust Advisors LP now owns 36,681 shares of the company’s stock valued at $2,687,000 after purchasing an additional 28,482 shares during the last quarter. Arizona State Retirement System increased its position in shares of Medidata Solutions by 1.0% during the 2nd quarter. Arizona State Retirement System now owns 45,188 shares of the company’s stock valued at $4,090,000 after purchasing an additional 469 shares during the last quarter. ARP Americas LP bought a new position in shares of Medidata Solutions during the 2nd quarter valued at about $35,960,000. Janney Montgomery Scott LLC bought a new position in shares of Medidata Solutions during the 2nd quarter valued at about $214,000. Finally, Dupont Capital Management Corp bought a new position in shares of Medidata Solutions during the 2nd quarter valued at about $4,390,000. Hedge funds and other institutional investors own 93.30% of the company’s stock.

MDSO opened at $92.22 on Thursday. The stock’s 50 day simple moving average is $92.16 and its 200 day simple moving average is $91.51. The company has a debt-to-equity ratio of 0.27, a current ratio of 2.56 and a quick ratio of 2.56. Medidata Solutions Inc has a 1 year low of $60.10 and a 1 year high of $98.60. The firm has a market cap of $5.76 billion, a price-to-earnings ratio of 96.06, a PEG ratio of 6.95 and a beta of 1.22.

Several brokerages have recently commented on MDSO. BidaskClub upgraded Medidata Solutions from a “sell” rating to a “hold” rating in a research report on Tuesday, October 1st. Zacks Investment Research upgraded Medidata Solutions from a “hold” rating to a “buy” rating and set a $96.00 price objective on the stock in a research report on Wednesday, October 23rd. Finally, ValuEngine lowered Medidata Solutions from a “buy” rating to a “hold” rating in a research report on Wednesday, October 2nd. Ten analysts have rated the stock with a hold rating and one has issued a buy rating to the company’s stock. The company presently has a consensus rating of “Hold” and an average price target of $87.35.

Medidata Solutions Profile

Medidata Solutions, Inc provides cloud-based solutions for life sciences worldwide. It offers the Medidata Clinical Cloud, a platform, pioneering analytics, and clinical technology for the development and commercialization of new therapies. The company's platform solutions include data capture and management, and trial planning and management.

Read More: Technical Analysis

Institutional Ownership by Quarter for Medidata Solutions (NASDAQ:MDSO)

Receive News & Ratings for Medidata Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medidata Solutions and related companies with MarketBeat.com's FREE daily email newsletter.